Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03491709
What this trial is testing

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Who this might be right for
Colorectal Cancer
Dragonboat Biopharmaceutical Company Limited 18
Testing effectiveness (Phase 2)Looking for participantsNCT07070232
What this trial is testing

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 1,438
Early research (Phase 1)Study completedNCT04123886
What this trial is testing

A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion

Who this might be right for
Malignant Pleural Effusion
Sichuan Clover Biopharmaceuticals, Inc. 14
Not applicableUnknownNCT05745454
What this trial is testing

A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors

Who this might be right for
Solid Tumor
su haichuan 12
Early research (Phase 1)Looking for participantsNCT05471856
What this trial is testing

Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

Who this might be right for
Solid Tumors
Boehringer Ingelheim 66
Early research (Phase 1)Looking for participantsNCT06492122
What this trial is testing

Study With [225Ac]Ac-FL-020 in mCRPC Participants

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Full-Life Technologies UK Limited 50
Early research (Phase 1)Study completedNCT00051675
What this trial is testing

Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas

Who this might be right for
Adenocarcinoma
XOMA (US) LLC 30
Not applicableStudy completedNCT06132607
What this trial is testing

3D Lung Reconstructions Using Open-source Software for Lung Cancer Surgery

Who this might be right for
Lung CancerThoracic Surgery, Video-AssistedLobectomy+3 more
Erik de Loos 13
Testing effectiveness (Phase 2)Looking for participantsNCT07670312
What this trial is testing

Evaluation of XYA02 in Patients With Advanced Solid Tumors

Who this might be right for
MUC1-expressing Advanced, Relapsed and/or Refractory Solid TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
XYone Therapeutics, Inc 190
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06763965
What this trial is testing

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Who this might be right for
Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd 30
Large-scale testing (Phase 3)Study completedNCT01302834
What this trial is testing

Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerPrecancerous Condition
Radiation Therapy Oncology Group 987
Early research (Phase 1)Looking for participantsNCT07193628
What this trial is testing

B7H3/IL13Ra2 Bispecific Armored Chimeric Antigen Receptor T-Cell Therapy Study for Recurrent/Refractory Glioblastoma

Who this might be right for
Refractory GlioblastomaRecurrent Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 14
Not applicableUnknownNCT03759899
What this trial is testing

HAECs Are Preliminarily Applied in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT01288092
What this trial is testing

BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT05472311
What this trial is testing

Cervical Cancer Elimination -Using Implementation Science to Evaluate Deliver and Cost Introduction of Thermal Ablation

Who this might be right for
Cervical Cancer
University of Washington 565
Not applicableLooking for participantsNCT06672302
What this trial is testing

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasm
EXoPERT 330
Testing effectiveness (Phase 2)Looking for participantsNCT07178301
What this trial is testing

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Northwestern University 100
Not applicableStudy completedNCT02425800
What this trial is testing

Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells

Who this might be right for
Benign Prostatic HyperplasiaProstate Carcinoma
Wake Forest University Health Sciences 43
Testing effectiveness (Phase 2)Study completedNCT02395822
What this trial is testing

MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients

Who this might be right for
Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 17
Testing effectiveness (Phase 2)Looking for participantsNCT05307939
What this trial is testing

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Who this might be right for
HPVOropharynx CancerHPV-Related Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 30
Next Page